Company: SCYX
Filing Date: 2025-03-12
Form Type: 10-K
Source: 0000950170-25-038044
Chunk: 148

Company: SCYNEXIS INC
Filing Date: 2025-03-12
Form: 10-K
Item: Item 1B
Chunk 148
---
,374

        Warrants to purchase common stock associated with December 2020 public offering - Series 2

        —

        6,800,000

        Prefunded warrants to purchase common stock associated with December 2020 public offering

        3,200,000

        3,200,000

        Warrants to purchase common stock associated with April 2022 Public Offering

        15,000,000

        15,000,000

        Prefunded warrants to purchase common stock associated with April 2022 Public Offering

        7,516,267

        7,516,267

        Warrants to purchase common stock associated with Loan Agreement

        198,811

        198,811

        Warrants to purchase common stock associated with Danforth

        50,000

        50,000

        For possible future issuance for the conversion of the March 2019 Notes

        1,138,200

        1,138,200

        For possible future issuance under 2014 Plan (Note 11)

        —

        848,202

        For possible future issuance under 2024 Plan  (Note 11)

        5,864,196

        —

        For possible future issuance under employee stock purchase plan

        1,431,393

        1,474,045

        For possible future issuance under 2015 Plan (Note 11)

        637,050

        633,590

        Total common shares reserved for future issuance

        41,061,320

        40,613,284

      Liquidation RightsIn the event of any liquidation or dissolution of the Company, the holders of the common stock are entitled to the remaining assets of the Company legally available for distribution.Dividends and Voting RightsThe holders of the common stock are entitled to receive dividends if and when declared by the Company.  Preferred StockOn May 7, 2014, the Company amended and restated its articles of incorporation relating to its approved capital structure. The Company’s board of directors has authorized the Company, subject to limitations prescribed by Delaware law, to issue up to 5,000,000 shares of preferred stock with a par value of $0.001 per share in one or more series, to establish from time to time the number of shares to be included in each series and to fix the designation, powers, preferences and rights of the shares of each series